Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NGL FINE CHM Plunges 4%; BSE HEALTHCARE Index Up 0.2%
Wed, 11 Sep 14:30

NGL FINE CHM Plunges 4%; BSE HEALTHCARE Index Up 0.2%Image source: peterschreiber.media/www.istockphoto.com

NGL FINE CHM share price has plunged 4% and is presently trading at Rs 2,085.0.

Meanwhile, the BSE HEALTHCARE index is at 43,922.5 (up 0.2%).

Among the top losers in the BSE HEALTHCARE index today are SUN PHARMA ADV. RES. (down 2.5%) and GRANULES INDIA (down 2.3%).

HIKAL CHEMIC (up 4.5%) and Natco Pharma (up 4.0%) are among the top gainers today.

Over the last one year, NGL FINE CHM has moved up from Rs 1,997.4 to Rs 2,085.0, registering a gain of Rs 87.6 (up 4.4%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,436.8 to 43,922.5, registering a gain of 54.5% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were SUVEN PHARMACEUTICALS (up 130.3%), Jubilant Pharmova (up 129.6%) and GRANULES INDIA (up 116.1%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,601.1 (down 0.4%).

The top losers among the BSE Sensex today are Tata Motors (down 5.9%) and M&M (down 1.6%). The most traded stocks in the BSE Sensex are Tata Motors and Tata Steel.

In the meantime, NSE Nifty is at 24,940.3 (down 0.4%). Tata Motors and ONGC are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 67,127.1 to 81,601.1, registering a gain of 14,474.0 points (up 21.6%).

NGL FINE CHM Financial Update...

NGL FINE CHM net profit grew 8.4% YoY to Rs 92 million for the quarter ended June 2024, compared to a profit of Rs 85 million a year ago. Net sales rose 27.7% to Rs 908 million during the period as against Rs 710 million in April-June 2023.

For the year ended March 2024, NGL FINE CHM reported 101.6% increase in net profit to Rs 413 million compared to net profit of Rs 205 million during FY23. Revenue of the company grew 21.8% to Rs 3,387 million during FY24.

The current Price to earnings ratio of NGL FINE CHM, based on rolling 12 month earnings, stands at 30.6.


Equitymaster requests your view! Post a comment on "NGL FINE CHM Plunges 4%; BSE HEALTHCARE Index Up 0.2%". Click here!